Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours.
Raymond E, Kulke MH, Qin S, Yu X, Schenker M, Cubillo A, Lou W, Tomasek J, Thiis-Evensen E, Xu JM, Croitoru AE, Khasraw M, Sedlackova E, Borbath I, Ruff P, Oberstein PE, Ito T, Jia L, Hammel P, Shen L, Shrikhande SV, Shen Y, Sufliarsky J, Khan GN, Morizane C, Galdy S, Khosravan R, Fernandez KC, Rosbrook B, Fazio N. Raymond E, et al. Among authors: fazio n. Neuroendocrinology. 2018;107(3):237-245. doi: 10.1159/000491999. Epub 2018 Jul 10. Neuroendocrinology. 2018. PMID: 29991024
ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors.
Kianmanesh R, Ruszniewski P, Rindi G, Kwekkeboom D, Pape UF, Kulke M, Sevilla Garcia I, Scoazec JY, Nilsson O, Fazio N, Lesurtel M, Chen YJ, Eriksson B, Cioppi F, O'Toole D; Palma de Mallorca Consensus Conference Participants. Kianmanesh R, et al. Among authors: fazio n. Neuroendocrinology. 2010;91(4):333-40. doi: 10.1159/000286700. Epub 2010 Apr 29. Neuroendocrinology. 2010. PMID: 20424420 No abstract available.
Chemotherapy in pancreatic adenocarcinoma.
Squadroni M, Fazio N. Squadroni M, et al. Among authors: fazio n. Eur Rev Med Pharmacol Sci. 2010 Apr;14(4):386-94. Eur Rev Med Pharmacol Sci. 2010. PMID: 20496553 Review.
Risk factors for disease progression in advanced jejunoileal neuroendocrine tumors.
Panzuto F, Campana D, Fazio N, Brizzi MP, Boninsegna L, Nori F, Di Meglio G, Capurso G, Scarpa A, Dogliotti L, De Braud F, Tomassetti P, Delle Fave G, Falconi M. Panzuto F, et al. Among authors: fazio n. Neuroendocrinology. 2012;96(1):32-40. doi: 10.1159/000334038. Epub 2011 Dec 28. Neuroendocrinology. 2012. PMID: 22205326
RAF signaling in neuroendocrine neoplasms: from bench to bedside.
Fazio N, Abdel-Rahman O, Spada F, Galdy S, De Dosso S, Capdevila J, Scarpa A. Fazio N, et al. Cancer Treat Rev. 2014 Sep;40(8):974-9. doi: 10.1016/j.ctrv.2014.06.009. Epub 2014 Jun 25. Cancer Treat Rev. 2014. PMID: 24998490 Review.
375 results